DEUTSCHE BANK AG\ - ACASTI PHARMA INC ownership

ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 13 filers reported holding ACASTI PHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q4 2019$190,000
+2614.3%
77,700
+1142.6%
0.00%
Q2 2019$7,000
-70.8%
6,253
-74.5%
0.00%
Q1 2019$24,000
-89.9%
24,500
-90.3%
0.00%
Q4 2017$238,000252,603
+117389.8%
0.00%
Q4 2015$02150.00%
Other shareholders
ACASTI PHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
INTACT INVESTMENT MANAGEMENT INC. 48,990$81,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 40,000$52,0000.00%
BANK OF MONTREAL /CAN/ 154,427$199,0000.00%
BREWIN DOLPHIN LTD 30$390.00%
Renaissance Technologies 61,195$79,0000.00%
ROYAL BANK OF CANADA 4,075$5,0000.00%
View complete list of ACASTI PHARMA INC shareholders